Nemvaleukin Alfa Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Cutaneous or Mucosal Melanoma - ARTISTRY-6

Clinical trial NCT04830124 · TERMINATED

Trial details

NCT number: NCT04830124
Sponsor: Mural Oncology, Inc
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Cutaneous Melanoma Mucosal Melanoma

Start date: 2021-09-27
Primary completion: 2025-05-08
Enrollment: 173

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.